| - GRCh37:
- Chr16:28943345
- GRCh38:
- Chr16:28932024
| CD19 | F8L | Immunodeficiency, common variable, 3 | Uncertain significance (Jun 28, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr16:28949986
- GRCh38:
- Chr16:28938665
| CD19 | | not provided, Immunodeficiency, common variable, 3 | Conflicting interpretations of pathogenicity (May 12, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:28947872
- GRCh38:
- Chr16:28936551
| CD19 | Q256H, Q345H | Immunodeficiency, common variable, 3, Immunodeficiency, common variable, 2, not provided
| Uncertain significance (Aug 7, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:28943806
- GRCh38:
- Chr16:28932485
| CD19 | R76S | not provided, Immunodeficiency, common variable, 3 | Uncertain significance (Aug 15, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:28949164
- GRCh38:
- Chr16:28937843
| CD19 | | not provided, Immunodeficiency, common variable, 3 | Benign (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:28943368
- GRCh38:
- Chr16:28932047
| CD19 | M16T | Immunodeficiency, common variable, 3 | Likely benign (May 21, 2020) | no assertion criteria provided |
| - GRCh37:
- Chr16:28946783
- GRCh38:
- Chr16:28935462
| CD19 | L285P | not provided | Uncertain significance (Jan 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:28947515
- GRCh38:
- Chr16:28936194
| CD19 | T330A | not provided, Immunodeficiency, common variable, 3 | Uncertain significance (Oct 27, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:28946775
- GRCh38:
- Chr16:28935454
| CD19 | H282Q | not provided, Immunodeficiency, common variable, 3 | Uncertain significance (Aug 16, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:28944783
- GRCh38:
- Chr16:28933462
| CD19 | R263H | not provided, Immunodeficiency, common variable, 3 | Uncertain significance (May 30, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:28944682
- GRCh38:
- Chr16:28933361
| CD19 | E229D | Immunodeficiency, common variable, 3 | Uncertain significance (Apr 27, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr16:28944406
- GRCh38:
- Chr16:28933085
| CD19 | R177T | Immunodeficiency, common variable, 3 | Uncertain significance (Jan 15, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr16:28944364
- GRCh38:
- Chr16:28933043
| CD19 | R163H | Immunodeficiency, common variable, 3, not provided | Uncertain significance (Aug 20, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:28950650
- GRCh38:
- Chr16:28939329
| CD19 | | Immunodeficiency, common variable, 3 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr16:28943901
- GRCh38:
- Chr16:28932580
| CD19 | Q108P | Immunodeficiency, common variable, 3, not provided | Conflicting interpretations of pathogenicity (Jul 7, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:28943824
- GRCh38:
- Chr16:28932503
| CD19 | | Immunodeficiency, common variable, 3 | Uncertain significance (Apr 27, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr16:28950511
- GRCh38:
- Chr16:28939190
| CD19 | | Immunodeficiency, common variable, 3 | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr16:28949129
- GRCh38:
- Chr16:28937808
| CD19 | R490Q | Immunodeficiency, common variable, 3, not provided | Uncertain significance (Aug 13, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:28943382
- GRCh38:
- Chr16:28932061
| CD19 | E21Q | Immunodeficiency, common variable, 3, not provided | Uncertain significance (Feb 8, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:28943756
- GRCh38:
- Chr16:28932435
| CD19 | P60S | not provided, Immunodeficiency, common variable, 3 | Uncertain significance (Jan 14, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:28948459
- GRCh38:
- Chr16:28937138
| CD19 | | Immunodeficiency, common variable, 3 | Likely pathogenic (Jul 5, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr16:28943725
- GRCh38:
- Chr16:28932404
| CD19 | | not provided, Immunodeficiency, common variable, 3 | Conflicting interpretations of pathogenicity (Oct 16, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:28947879
- GRCh38:
- Chr16:28936558
| CD19 | Y348H, Y259H | Immunodeficiency, common variable, 3 | Uncertain significance (Apr 27, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr16:28950248
- GRCh38:
- Chr16:28938927
| CD19 | G547fs, G457fs | not provided, Immunodeficiency, common variable, 3 | Conflicting interpretations of pathogenicity (Jul 30, 2021) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:28950626
- GRCh38:
- Chr16:28939305
| CD19 | | Immunodeficiency, common variable, 3 | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr16:28950597
- GRCh38:
- Chr16:28939276
| CD19 | | Immunodeficiency, common variable, 3 | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr16:28950546
- GRCh38:
- Chr16:28939225
| CD19 | | Immunodeficiency, common variable, 3 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr16:28950517
- GRCh38:
- Chr16:28939196
| CD19 | | Immunodeficiency, common variable, 3 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr16:28950483
- GRCh38:
- Chr16:28939162
| CD19 | | Immunodeficiency, common variable, 3 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr16:28950295
- GRCh38:
- Chr16:28938974
| CD19 | | Immunodeficiency, common variable, 3 | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr16:28950189
- GRCh38:
- Chr16:28938868
| CD19 | | not provided, Immunodeficiency, common variable, 3 | Conflicting interpretations of pathogenicity (Oct 20, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:28950179
- GRCh38:
- Chr16:28938858
| CD19 | | not provided, Immunodeficiency, common variable, 3 | Conflicting interpretations of pathogenicity (Apr 15, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:28950051
- GRCh38:
- Chr16:28938730
| CD19 | R514H, R515H | not provided, not specified, Immunodeficiency, common variable, 3
| Benign (Nov 3, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:28948843
- GRCh38:
- Chr16:28937522
| CD19 | | not provided, Immunodeficiency, common variable, 3 | Uncertain significance (Jan 14, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:28948783
- GRCh38:
- Chr16:28937462
| CD19 | | not provided, Immunodeficiency, common variable, 3 | Benign/Likely benign (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:28948667
- GRCh38:
- Chr16:28937346
| CD19 | S425F, S336F | Immunodeficiency, common variable, 3, not provided | Conflicting interpretations of pathogenicity (Oct 24, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:28948597
- GRCh38:
- Chr16:28937276
| CD19 | E402K, E313K | not provided, Immunodeficiency, common variable, 3 | Uncertain significance (Jun 29, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:28946752
- GRCh38:
- Chr16:28935431
| CD19 | | not provided, Immunodeficiency, common variable, 3 | Conflicting interpretations of pathogenicity (Oct 31, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:28944700
- GRCh38:
- Chr16:28933379
| CD19 | | not provided, Immunodeficiency, common variable, 3 | Benign (Nov 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:28944403
- GRCh38:
- Chr16:28933082
| CD19 | P176L, P87L | not provided, Immunodeficiency, common variable, 3 | Uncertain significance (Aug 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:28944396
- GRCh38:
- Chr16:28933075
| CD19 | L174V | not provided, not specified, Immunodeficiency, common variable, 3
| Benign (Nov 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:28944282
- GRCh38:
- Chr16:28932961
| CD19 | | not provided, Immunodeficiency, common variable, 3 | Benign/Likely benign (Sep 14, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:28944271
- GRCh38:
- Chr16:28932950
| CD19 | L132R, L43R | not provided, Immunodeficiency, common variable, 3 | Conflicting interpretations of pathogenicity (Oct 25, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:28944266
- GRCh38:
- Chr16:28932945
| CD19 | | not provided, Immunodeficiency, common variable, 3 | Conflicting interpretations of pathogenicity (Oct 21, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:28944260
- GRCh38:
- Chr16:28932939
| CD19 | | not provided, Immunodeficiency, common variable, 3 | Conflicting interpretations of pathogenicity (Aug 23, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:28944257
- GRCh38:
- Chr16:28932936
| CD19 | | Immunodeficiency, common variable, 3, not provided | Benign/Likely benign (Oct 1, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:28943749
- GRCh38:
- Chr16:28932428
| CD19 | | not provided, Immunodeficiency, common variable, 3 | Conflicting interpretations of pathogenicity (Sep 14, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:28943338
- GRCh38:
- Chr16:28932017
| CD19 | L6R | Immunodeficiency, common variable, 3 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr16:28943306
- GRCh38:
- Chr16:28931985
| CD19 | | Immunodeficiency, common variable, 3 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr16:28950266-28950293
- GRCh38:
- Chr16:28938945-28938972
| CD19 | | Immunodeficiency, common variable, 3 | Pathogenic (Sep 13, 2016) | no assertion criteria provided |
| - GRCh37:
- Chr16:28949121
- GRCh38:
- Chr16:28937800
| CD19 | S489fs, S400fs | Immunodeficiency, common variable, 3 | Pathogenic (Sep 13, 2016) | no assertion criteria provided |
| - GRCh37:
- Chr16:28943734
- GRCh38:
- Chr16:28932413
| CD19 | W52C | Immunodeficiency, common variable, 3 | Pathogenic (Sep 13, 2016) | no assertion criteria provided |
| - GRCh37:
- Chr16:28947473
- GRCh38:
- Chr16:28936152
| CD19 | | Immunodeficiency, common variable, 3 | Pathogenic (Sep 13, 2016) | no assertion criteria provided |
| - GRCh37:
- Chr16:28944833
- GRCh38:
- Chr16:28933512
| CD19 | | not provided, Immunodeficiency, common variable, 3 | Uncertain significance (Jan 13, 2018) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:28948956-28948957
- GRCh38:
- Chr16:28937635-28937636
| CD19 | N374fs, N463fs | Immunodeficiency, common variable, 3 | Pathogenic (May 4, 2006) | no assertion criteria provided |
| - GRCh37:
- Chr16:28947495-28947496
- GRCh38:
- Chr16:28936174-28936175
| CD19 | R236fs, R325fs | Immunodeficiency, common variable, 3 | Pathogenic (May 4, 2006) | no assertion criteria provided |